Manatt Health June 28, 2023
Rachel L. Sher, Matthew C. Itzkowitz

On June 23, 2023, FDA issued a first-of-its-kind draft guidance for sponsors of studies of psychedelic drugs. The guidance arrived just as the Psychedelic Science 2023 conference in Denver was wrapping up. Touted as the “largest psychedelic conference in history,” the conference drew over 12,000 people, including an array of medical professionals, government officials (i.e., Dr. Joshua Gordon, Director of the National Institute of Mental Health (NIMH), and Commander Gene Gunn in FDA’s Office of Regulatory Affairs) and politicians (i.e., Colorado Governor Jared Polis and former Texas Governor Rick Perry). Additionally, recent activity on Capitol Hill demonstrates a growing interest by legislators in the field of psychedelic science. These events signal a significant shift in our cultural awareness and acceptance...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Mental Health, Provider
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article